Evidence map›Paper›PMID 35252755›Full record

ArticleAccess microbiology2022

Surveillance of SARS-CoV-2 RNA in open-water sewage canals contaminated with untreated wastewater in resource-constrained regions.

Paramita Basu, Sandeepan Choudhury, Varsha Shridhar, Poorva Huilgol, Samrat Roychoudhury, Indranil Nandi, Angela Chaudhuri, Arindam Mitra

Abstract read
In one paragraph

Article in Access microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paramita BasuDepartment of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, New York, USA.ORCID https://orcid.org/0000-0002-2053-2739
Sandeepan ChoudhuryIndependent water and wastewater consultant, India.ORCID https://orcid.org/0000-0002-2543-4521
Varsha ShridharMolecular Solutions Care Health, Bangalore, India.ORCID https://orcid.org/0000-0002-3219-3041
Poorva HuilgolMolecular Solutions Care Health, Bangalore, India.
Samrat RoychoudhuryIndian Academy Degree College, Bangalore, India.ORCID https://orcid.org/0000-0003-1013-2907
Indranil NandiJubilant Pharma, Yardley, USA.
Angela ChaudhuriSwasti Health Catalyst, Bangalore, India.
Arindam MitraDepartment of Microbiology, School of Life Science and Biotechnology, Adamas University, Kolkata, India.ORCID https://orcid.org/0000-0002-1591-6164

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sewage-based surveillance for COVID-19 has been described in multiple countries and multiple settings. However, nearly all are based on testing sewage treatment plant inflows and outflows using structured sewage networks and treatment systems. Many resource-limited countries worldwide have open canals, lakes and other such waste-contaminated water bodies that act as a means of sewage effluent discharge. These could serve as hyperlocal testing points for detecting COVID-19 incidence using the effluents from nearby communities. However, a sensitive, robust and economical method of SARS-CoV-2 RNA detection from open waste contaminated water bodies in resource-constrained regions is currently lacking. A protocol employed in Bangalore, India, where SARS-CoV-2 RNA levels were evaluated using two open canal systems during the first and second waves in the present study. SARS-CoV-2 RNA was measured using two strategies: a modified TrueNAT

Indexed as

COVID-19hyper localized surveillanceopen-water sewage canalsSARS-CoV-2untreated wastewater

Identifiers

PMID35252755
PMCPMC8895599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.